Lymphir
![Citiusā IL-2 Therapy Fails to Win FDA Approval for Lymphoma](https://pharmtales.com/wp-content/uploads/2023/07/FDA-rejects-Citius-resurrected-IL-2-lymphoma-treatment.jpg)
FDA rejects Citius’ resurrected IL-2 lymphoma treatment
SG Tylor
Source – Citius PharmaceuticalsĀ The FDA has declined Citius Pharmaceuticals’ request to market Lymphir, an updated version of a lymphoma ...
Source – Citius PharmaceuticalsĀ The FDA has declined Citius Pharmaceuticals’ request to market Lymphir, an updated version of a lymphoma ...